Hunan Er-Kang Pharmaceutical Co Ltd 300267.SZ

Last Updated: May 15, 12:00 AM·SZSE

Hunan Er-Kang Pharmaceutical Co Ltd

Hunan Er-Kang Pharmaceutical Co Ltd. Stock Analysis 300267.SZ

China Health Care Small Cap
Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 1,271 full-time employees. The company went IPO on 2011-09-27. The Company’s pharmaceutical excipients mainly consist of glycerol for medicine, sugar for medicine, ethanol for medicine, propylene glycol for medicine, as well as sodium hydroxide for medicine and others. Its bulk drugs consist of sulfadiazine, sulphaguanidine and resorcinol, among others. Its finished drugs consist of sulbenicillin sodium injections and compound liquorice tablets. The firm distributes its products in domestic market and to overseas markets.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.